Cargando…

Angiotensin-II stimulating vs. inhibiting antihypertensive drugs and the risk of Alzheimer's disease or related dementia in a large cohort of older patients with colorectal cancer

BACKGROUND: Several previous studies showed that patients who received angiotensin II–stimulating antihypertensive medications had a lower incident dementia rate than those angiotensin II–inhibiting antihypertensive users, but no study has been conducted in long-term cancer survivors. OBJECTIVES: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xianglin L., Li, Zhuoyun, Schulz, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196474/ https://www.ncbi.nlm.nih.gov/pubmed/37215552 http://dx.doi.org/10.3389/fcvm.2023.1136475

Ejemplares similares

Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries
por: Marcum, Zachary A., et al.
Publicado: (2023)

Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
por: Marcum, Zachary A., et al.
Publicado: (2022)

Association of Angiotensin II–Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial
por: van Dalen, Jan Willem, et al.
Publicado: (2021)

Associations Between Vascular Diseases and Alzheimer’s Disease or Related Dementias in a Large Cohort of Men and Women with Colorectal Cancer
por: Du, Xianglin L., et al.
Publicado: (2022)

The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT–Medicare linked data
por: Du, Xianglin L., et al.
Publicado: (2023)

SAT-562 Angiotensin II Induces Aldosterone Synthesis in the Rat Heart Stressed by Angiotensin II
por: Bose, Himangshu S, et al.
Publicado: (2020)

Antihypertensive Effects of Standardized Asafoetida: Effect on Hypertension Induced by Angiotensin II
por: Kazemi, Farzaneh, et al.
Publicado: (2020)

Redox-sensitive calcium/calmodulin-dependent protein kinase IIα in angiotensin II intra-neuronal signaling and hypertension
por: Basu, Urmi, et al.
Publicado: (2019)

Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor
por: Barhoumi, Tlili, et al.
Publicado: (2023)

Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
por: AlSiraj, Yasir, et al.
Publicado: (2021)

Angiotensin II during Experimentally Simulated Central Hypovolemia
por: Jensen, Theo Walther, et al.
Publicado: (2016)

The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents
por: MacDonald, T M, et al.
Publicado: (2010)

Use of Antihypertensive Drugs During Preeclampsia
por: Odigboegwu, Obinnaya, et al.
Publicado: (2018)

Use of Antihypertensive Drugs and Ischemic Stroke Severity – Is There a Role for Angiotensin-II?
por: Hwong, Wen Yea, et al.
Publicado: (2016)

Interlinking Antecedent Malaria and Hypertension Through Angiotensin II in India
por: Tiwari, Aparna, et al.
Publicado: (2021)

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
por: Camargo, Rafael L., et al.
Publicado: (2022)

Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
por: Rudolph, Ulrike Maria, et al.
Publicado: (2020)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019
por: van Lier, Dirk, et al.
Publicado: (2022)

Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension
por: Lubas, Arkadiusz, et al.
Publicado: (2010)

Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats
por: Jin, Kyubok, et al.
Publicado: (2013)

Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Bryniarski, Paweł, et al.
Publicado: (2022)

Factors affecting the changes in antihypertensive medications in patients with hypertension
por: Chung, Tae Kyu, et al.
Publicado: (2022)

Risk of Developing Alzheimer’s Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up
por: Du, Xianglin L., et al.
Publicado: (2022)

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment
por: Pandya, Nischal R., et al.
Publicado: (2018)

Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
por: Agostinucci, Kevin, et al.
Publicado: (2022)

OR04-5 Stimulation of Protein Disulfide Isomerase Activity by Activation of The Renin-Angiotensin System
por: Irizarry, Jose, et al.
Publicado: (2019)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
por: Ren, Kai-Wen, et al.
Publicado: (2022)

Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy
por: Clemmer, John S., et al.
Publicado: (2020)

Narrative update of clinical trials with antihypertensive drugs in children and adolescents
por: Redon, Josep, et al.
Publicado: (2022)

Association of combination statin and antihypertensive therapy with reduced Alzheimer’s disease and related dementia risk
por: Barthold, Douglas, et al.
Publicado: (2020)

SAT-LB90 Angiotensin II and ACTH Receptor Expression in Aldosterone-Producing Adenomas
por: Lim, Jung Soo, et al.
Publicado: (2020)

Loss of Angiotensin II Type 2 Receptor Improves Blood Pressure in Elastin Insufficiency
por: Lin, Michelle, et al.
Publicado: (2021)

Proteasome inhibition reduces plasma cell and antibody secretion, but not angiotensin II-induced hypertension
por: Figueiredo Galvao, Hericka Bruna, et al.
Publicado: (2023)

Racial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancer
por: Du, Xianglin L., et al.
Publicado: (2022)

Corrigendum: Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy
por: Clemmer, John S., et al.
Publicado: (2021)

Antihypertensives in dementia: Good or bad for the brain?
por: Beishon, Lucy, et al.
Publicado: (2022)

Antihypertensives in dementia: Good or bad for the brain?
por: Heutz, Rachel AM, et al.
Publicado: (2023)

Cardiomyocyte-specific deletion of TLR4 attenuates angiotensin II-induced hypertension and cardiac remodeling
por: Theobald, Drew, et al.
Publicado: (2023)

THU596 Heteromerization Of The Angiotensin II Type 1 Receptor And The Bradykinin Type 2 Receptor
por: Johnstone, Elizabeth K M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jh4lisnbcgtg33rrhv8d5p1e8p